(1S,3R)-1,2,2-Trimethylcyclopentane-1,3-dicarboxylic acid, 95.0%, 5g

Methyl 4-(1,3-Oxazol-5-yl)benzoate, 97.0%, 5g

L-(-)-Cystine Dihydrochloride>98.0%(HPLC)25g

(2S,5R)-Benzyl 5-((benzyloxy)amino)piperidine-2-carboxylate oxalate, 98%, 5g

2-(Difluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95%, 100mg

2-BROMOINDAN, 97.0%, 10g

2-(3,4-Dichlorophenyl)-2-fluoroacetic acid, 95%, 100mg

Benzenaminium, 3-carboxy-4-iodyl-N,N,N-trimethyl-, inner salt(AIBX), 98%, 1g

2-Butyl-3-[[2'-cyano-[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4,4]non-1-en-4-one>97.0%(N)5g

6-ethyl-2-piperazin-1-yl-1,3-benzothiazole, 95.0%, 500mg

(R)-1-(5-Bromothiophen-2-yl)ethan-1-amine hydrochloride, 95%, 500mg

Tetrabutylammonium hydroxide (10% solution in water), 95.0%, 500g

(S)-3-Amino-2-oxo-azepane hydrochloride, 95.0%, 25g